CPGJ602

DB17485Investigational

CPGJ602 is a recombinant anti-EGFR human-mouse chimeric monoclonal antibody.

Mechanism: Pharmacologically active on Epidermal growth factor receptor
Curator reviewed
Code names: CPGJ-602

Resolves to

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with CPGJ602, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.